Request for Nominations of Candidates To Serve on the Board of Scientific Counselors (BSC), National Institute for Occupational Safety and Health (NIOSH), 92821 [2016-30522]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 244 / Tuesday, December 20, 2016 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket Number NIOSH 278]
Request for Nominations of
Candidates To Serve on the Board of
Scientific Counselors (BSC), National
Institute for Occupational Safety and
Health (NIOSH)
The Centers for Disease Control and
Prevention (CDC) is soliciting
nominations for possible membership
on the BSC, NIOSH.
The BSC, NIOSH consists of 15
experts in fields related to occupational
safety and health. The members are
selected by the Secretary of the U.S.
Department of Health and Human
Services (HHS). The board advises the
NIOSH Director on occupational safety
and health research and prevention
programs. The board also provides
advice on standards of scientific
excellence, current needs in the field of
occupational safety and health, and the
applicability and dissemination of
research findings. This advice may take
the form of reports or verbal
communications to the NIOSH Director
during BSC meetings. Nominations are
being sought for individuals who have
expertise and qualifications necessary to
contribute to the accomplishment of the
board’s mission. More information is
available on the NIOSH BSC Web site:
https://www.cdc.gov/niosh/BSC/
default.html.
Nominees will be selected based on
expertise in occupational safety and
health fields, such as occupational
medicine, occupational nursing,
industrial hygiene, occupational safety
and health engineering, toxicology,
chemistry, safety and health education,
ergonomics, epidemiology, biostatistics,
and psychology. Members may be
invited to serve for terms of two to four
years. Selected nominees would begin
service on the BSC, NIOSH in January
2018.
The U.S. Department of Health and
Human Services policy stipulates that
committee membership shall be
balanced in terms of points of view
represented, and the committee’s
function. Appointments shall be made
without discrimination on the basis of
age, race, ethnicity, gender, sexual
orientation, gender identity, HIV status,
disability, and cultural, religious, or
socioeconomic status. Nominees must
be U.S. citizens, and cannot be full-time
employees of the U.S. Government or
federally registered lobbyists. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Board
members are Special Government
Employees, requiring the filing of
financial disclosure reports at the
beginning and annually during their
terms. CDC reviews potential candidates
for the Board membership each year,
and provides a slate of nominees for
consideration to the Secretary of HHS
for final selection.
Candidates should submit the
following items:
• Current curriculum vitae, including
complete contact information (name,
affiliation, mailing address, telephone
number, email address)
• A letter of recommendation stating
the qualifications of the candidate.
Nominations must be submitted
(postmarked or electronically received)
by January 31, 2017.
Submissions must be electronic or by
mail. Submissions should reference
docket 278. Electronic submissions: You
may electronically submit nominations,
including attachments, to nioshdocket@
cdc.gov.
Attachments in Microsoft Word are
preferred. Regular, Express, or
Overnight Mail: Written nominations
may be submitted (one original and two
copies) to the following address only:
NIOSH Docket 278, c/o Richie
Dickerson, Committee Management
Specialist, National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention,
1600 Clifton Road NE., MS: E–20,
Atlanta, Georgia 30329. Telephone and
facsimile submissions cannot be
accepted.
The Director, Management Analysis
and Services Office, has been delegated
mstockstill on DSK3G9T082PROD with NOTICES
Application No.
065007
065016
065021
065059
065060
065081
065082
065083
.......................
.......................
.......................
.......................
.......................
.......................
.......................
.......................
VerDate Sep<11>2014
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–30522 Filed 12–19–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2016–N–4320]
Sun Pharmaceutical Industries, Inc.;
Withdrawal of Approval of 28
Abbreviated New Drug Applications
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is withdrawing
approval of 28 abbreviated new drug
applications held by Sun
Pharmaceutical Industries, Inc. (Sun
Pharmaceutical), U.S. Agent for Sun
Pharmaceutical Industries Limited, 270
Prospect Plains Rd., Cranbury, NJ
08512. The drug products are no longer
marketed, and Sun Pharmaceutical has
requested that the approval of the
applications be withdrawn.
DATES: January 19, 2017.
FOR FURTHER INFORMATION CONTACT:
Florine P. Purdie, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 51, Rm. 6248,
Silver Spring, MD 20993–0002, 301–
796–3601.
SUPPLEMENTARY INFORMATION: The
applications listed in the table in this
document are no longer marketed, and
Sun Pharmaceutical has requested that
FDA withdraw approval of the
applications. The company has also, by
its request, waived its opportunity for a
hearing.
SUMMARY:
Drug
Cephalexin Capsules USP, Equivalent to (EQ) 250 milligrams (mg) base and EQ 500 mg base.
Amoxicillin Capsules USP, 250 mg and 500 mg.
Amoxicillin Tablets USP (Chewable), 125 mg and 250 mg.
Amoxicillin Tablets USP, 500 mg and 875 mg.
Amoxicillin Tablets USP (Chewable), 200 mg and 400 mg.
Cephalexin for Oral Suspension USP, EQ 125 mg base/5 milliliters (mL) and EQ 250 mg base/5 mL.
Cefpodoxime Proxetil for Oral Suspension USP, EQ 50 mg base/5 mL and EQ 100 mg base/5 mL.
Cefpodoxime Proxetil Tablets USP, EQ 100 mg base and EQ 200 mg base.
19:36 Dec 19, 2016
Jkt 241001
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
92821
E:\FR\FM\20DEN1.SGM
20DEN1
]]>Agencies
[Federal Register Volume 81, Number 244 (Tuesday, December 20, 2016)]
[Notices]
[Page 92821]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-30522]
[[Page 92821]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket Number NIOSH 278]
Request for Nominations of Candidates To Serve on the Board of
Scientific Counselors (BSC), National Institute for Occupational Safety
and Health (NIOSH)
The Centers for Disease Control and Prevention (CDC) is soliciting
nominations for possible membership on the BSC, NIOSH.
The BSC, NIOSH consists of 15 experts in fields related to
occupational safety and health. The members are selected by the
Secretary of the U.S. Department of Health and Human Services (HHS).
The board advises the NIOSH Director on occupational safety and health
research and prevention programs. The board also provides advice on
standards of scientific excellence, current needs in the field of
occupational safety and health, and the applicability and dissemination
of research findings. This advice may take the form of reports or
verbal communications to the NIOSH Director during BSC meetings.
Nominations are being sought for individuals who have expertise and
qualifications necessary to contribute to the accomplishment of the
board's mission. More information is available on the NIOSH BSC Web
site: https://www.cdc.gov/niosh/BSC/default.html.
Nominees will be selected based on expertise in occupational safety
and health fields, such as occupational medicine, occupational nursing,
industrial hygiene, occupational safety and health engineering,
toxicology, chemistry, safety and health education, ergonomics,
epidemiology, biostatistics, and psychology. Members may be invited to
serve for terms of two to four years. Selected nominees would begin
service on the BSC, NIOSH in January 2018.
The U.S. Department of Health and Human Services policy stipulates
that committee membership shall be balanced in terms of points of view
represented, and the committee's function. Appointments shall be made
without discrimination on the basis of age, race, ethnicity, gender,
sexual orientation, gender identity, HIV status, disability, and
cultural, religious, or socioeconomic status. Nominees must be U.S.
citizens, and cannot be full-time employees of the U.S. Government or
federally registered lobbyists. Current participation on federal
workgroups or prior experience serving on a federal advisory committee
does not disqualify a candidate; however, HHS policy is to avoid
excessive individual service on advisory committees and multiple
committee memberships. Board members are Special Government Employees,
requiring the filing of financial disclosure reports at the beginning
and annually during their terms. CDC reviews potential candidates for
the Board membership each year, and provides a slate of nominees for
consideration to the Secretary of HHS for final selection.
Candidates should submit the following items:
Current curriculum vitae, including complete contact
information (name, affiliation, mailing address, telephone number,
email address)
A letter of recommendation stating the qualifications of
the candidate.
Nominations must be submitted (postmarked or electronically
received) by January 31, 2017.
Submissions must be electronic or by mail. Submissions should
reference docket 278. Electronic submissions: You may electronically
submit nominations, including attachments, to nioshdocket@cdc.gov.
Attachments in Microsoft Word are preferred. Regular, Express, or
Overnight Mail: Written nominations may be submitted (one original and
two copies) to the following address only: NIOSH Docket 278, c/o Richie
Dickerson, Committee Management Specialist, National Institute for
Occupational Safety and Health, Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS: E-20, Atlanta, Georgia 30329.
Telephone and facsimile submissions cannot be accepted.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the Centers for Disease Control and Prevention, and the Agency for
Toxic Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2016-30522 Filed 12-19-16; 8:45 am]
BILLING CODE 4163-18-P
